Jennifer Evans Stacey
CIK 1321326 · Chief Legal Officer · last filed 2026-05-04
Jennifer Evans Stacey is a Chief Legal Officer who has filed 27 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $375.0K of NEOG on May 4, 2026. Across all open-market trades the lifetime net is −$745.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $358.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$358.1K
5
27
-$745.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEOG | Chief Legal Officer | 39,349 | $9.10 | $358.1K | $0 | 1 | 2026-05-04 |
| CNTX | Director | — | $1.39 | — | $0 | 4 | 2025-06-12 |
| Galera Therapeutics, Inc. (GRTX) Delisted | See Remarks | — | $0.14 | — | $0 | 3 | 2023-02-28 |
| ANTARES PHARMA, INC. (ATRS) Delisted | SVP, General Counsel & Secty | 92,042 | $5.59 | $514.5K | $0 | 2 | 2015-06-01 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Executive VP & General Counsel | 16,878 | — | — | -$745.2K | 17 | 2011-04-04 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-04 | NEOG | Grant (A) | +39,349 | $375.0K | EDGAR |
| 2025-06-12 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2023-05-31 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2023-02-28 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-12 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-01 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +67,770 | -$5.4K | EDGAR |
| 2015-03-12 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | — | $0 | EDGAR |